BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11249135)

  • 1. High affinity central benzodiazepine receptor ligands. Part 2: quantitative structure-activity relationships and comparative molecular field analysis of pyrazolo[4,3-c]quinolin-3-ones.
    Savini L; Chiasserini L; Pellerano C; Biggio G; Maciocco E; Serra M; Cinone N; Carrieri A; Altomare C; Carotti A
    Bioorg Med Chem; 2001 Feb; 9(2):431-44. PubMed ID: 11249135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity central benzodiazepine receptor ligands: synthesis and structure-activity relationship studies of a new series of pyrazolo[4,3-c]quinolin-3-ones.
    Savini L; Massarelli P; Nencini C; Pellerano C; Biggio G; Maciocco A; Tuligi G; Carrieri A; Cinone N; Carotti A
    Bioorg Med Chem; 1998 Apr; 6(4):389-99. PubMed ID: 9597183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity central benzodiazepine receptor ligands. Part 3: insights into the pharmacophore and pattern recognition study of intrinsic activities of pyrazolo[4,3-c]quinolin-3-ones.
    Carotti A; Altomare C; Savini L; Chiasserini L; Pellerano C; Mascia MP; Maciocco E; Busonero F; Mameli M; Biggio G; Sanna E
    Bioorg Med Chem; 2003 Nov; 11(23):5259-72. PubMed ID: 14604690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted 3-(2-benzoxazyl)-benzimidazol-2-(1H)-ones: a new class of GABA(A) brain receptor ligands.
    DeSimone RW; Blum CA
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2723-6. PubMed ID: 11133077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel 2-phenyl-2H-pyrazolo[4,3-c]isoquinolin-3-ols: topological comparisons with analogues of 2-phenyl-2,5-dihydropyrazolo[4,3-c]quinolin-3(3H)-ones at benzodiazepine receptors.
    Allen MS; Skolnick P; Cook JM
    J Med Chem; 1992 Jan; 35(2):368-74. PubMed ID: 1310121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic heteroaromatic systems. Synthesis and A1 and A2a adenosine binding activities of some 1-aryl-1,4-dihydro-3-methyl[1]benzopyrano[2,3-c] pyrazol-4-ones, 1-aryl-4,9-dihydro-3-methyl-1H-pyrazolo[3,4-b]quinolin-4- ones, and 1-aryl-1H-imidazo[4,5-b]quinoxalines.
    Catarzi D; Cecchi L; Colotta V; Filacchioni G; Martini C; Tacchi P; Lucacchini A
    J Med Chem; 1995 Apr; 38(8):1330-6. PubMed ID: 7731018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship investigations of the modulating effect of core substituents on the affinity of pyrazoloquinolinone congeners for the benzodiazepine receptor.
    Karolak-Wojciechowska J; Lange J; Ksiazek W; Gniewosz M; Rump S
    Farmaco; 1998; 53(8-9):579-85. PubMed ID: 10081821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship studies at the benzodiazepine receptor (BZR): a comparison of the substitutent effects of pyrazoloquinolinone analogs.
    Fryer RI; Zhang P; Rios R; Gu ZQ; Basile AS; Skolnick P
    J Med Chem; 1993 May; 36(11):1669-73. PubMed ID: 8388472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and interaction of 5-(substituted-phenyl)-3-methyl-6,7-dihydropyrazolo[4,3-e] [1,4]diazepin-8(7H)-ones with benzodiazepine receptors in rat cerebral cortex.
    Baraldi PG; Manfredini S; Periotto V; Simoni D; Guarneri M; Borea PA
    J Med Chem; 1985 May; 28(5):683-5. PubMed ID: 2985787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tricyclic heteroaromatic systems. Synthesis and benzodiazepine binding activity of 1-substituted-3-methyl- and 3-phenylpyrazolo[4,5-c]quinolin-4-ones.
    Colotta V; Cecchi L; Melani F; Catarzi D; Filacchioni G; Martini C; Giannaccini G; Tonelli M; Lucacchini A
    Drug Des Discov; 1992 Jul; 8(4):325-39. PubMed ID: 1332785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structure-activity relationship study of the affinity of selected imidazo[1,2-a]pyridine derivatives, congeners of zolpidem, for the omega 1-subtype of the benzodiazepine receptor.
    Lange J; Karolak-Wojciechowska J; Wejroch K; Rump S
    Acta Pol Pharm; 2001; 58(1):43-52. PubMed ID: 11370287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling.
    Anzini M; Cappelli A; Vomero S; Seeber M; Menziani MC; Langer T; Hagen B; Manzoni C; Bourguignon JJ
    J Med Chem; 2001 Apr; 44(8):1134-50. PubMed ID: 11312914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazoloquinazolinediones as novel high affinity ligands for the benzodiazepine site of GABA(A) receptors.
    Nilsson J; Gidlöf R; Nielsen EØ; Liljefors T; Nielsen M; Sterner O
    Bioorg Med Chem; 2011 Jan; 19(1):111-21. PubMed ID: 21163663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: synthesis and benzodiazepine receptor activity.
    Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C
    Arch Pharm (Weinheim); 1997 Dec; 330(12):383-6. PubMed ID: 9474897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thienylpyrazoloquinolines: potent agonists and inverse agonists to benzodiazepine receptors.
    Takada S; Shindo H; Sasatani T; Chomei N; Matsushita A; Eigyo M; Kawasaki K; Murata S; Takahara Y; Shintaku H
    J Med Chem; 1988 Sep; 31(9):1738-45. PubMed ID: 2842502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity.
    Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
    Arch Pharm (Weinheim); 1996 Dec; 329(12):529-34. PubMed ID: 9038420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.
    Cappelli A; Bini G; Valenti S; Giuliani G; Paolino M; Anzini M; Vomero S; Giorgi G; Giordani A; Stasi LP; Makovec F; Ghelardini C; Di Cesare Mannelli L; Concas A; Porcu P; Biggio G
    J Med Chem; 2011 Oct; 54(20):7165-75. PubMed ID: 21916402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of ligand-receptor interactions in GABA C receptor.
    Osolodkin DI; Chupakhin VI; Palyulin VA; Zefirov NS
    J Mol Graph Model; 2009 Apr; 27(7):813-21. PubMed ID: 19167917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of 2-aryl-2,5-dihydropyridazino [4,3-b]indol-3(3H)-ones at the benzodiazepine receptor.
    Palluotto F; Carotti A; Casini G; Campagna F; Genchi G; Rizzo M; De Sarro GB
    Bioorg Med Chem; 1996 Dec; 4(12):2091-104. PubMed ID: 9022974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of pyrazolo[4,3-c]quinolinones as high affinity GABA
    López Rivilli MJ; Turina AV; Bignante EA; Molina VH; Perillo MA; Briñon MC; Moyano EL
    Bioorg Med Chem; 2018 Aug; 26(14):3967-3974. PubMed ID: 29954681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.